Pap Smear Preparation and Timing Guidelines

Timing Relative to Menstrual Cycle

• For liquid‑based cytology, the test may be performed at any point in the cycle, including during menses; for conventional cytology, schedule the collection 10–20 days after the first day of menses to avoid heavy flow. CDC recommendation. 1
• In asymptomatic patients using conventional cytology who experience heavy menstrual flow, postpone and reschedule the test at the earliest convenient opportunity. CDC recommendation. 4

When to Proceed Despite Menstruation or Bleeding

• Do not defer screening when a patient presents with abnormal bleeding (intermenstrual, post‑coital, or post‑menopausal) because these symptoms may signal cervical pathology requiring immediate evaluation. American Cancer Society guidance. 3
• Do not postpone testing when the patient has limited access to care and is unlikely to return for follow‑up; proceed with the Pap smear at the scheduled visit. American Cancer Society guidance. 3

Management of Cervical Discharge

• The presence of mucopurulent discharge, bacterial vaginosis, or other cervical infections should not delay cytology testing; remove visible discharge with a saline‑soaked cotton swab before specimen collection. CDC recommendation. 1

Pre‑Test Patient Instructions (48 Hours Prior)

• Patients should avoid douching, vaginal intercourse, tampon use, and vaginal creams, foams, jellies, or other medications for 48 hours before the Pap smear to ensure optimal specimen quality. American Cancer Society guidance. 3

Special Populations

Pregnancy

• Use a cervical broom device or a spatula‑and‑swab combination for specimen collection; do not use cytobrushes because of theoretical risk to the mucous plug or amniotic sac. American Cancer Society guidance. 3
• The cervical broom is the preferred single‑sampling device for pregnant patients when a liquid‑based system is employed. American Cancer Society guidance. 3

Prior Cervical Dysplasia

• Women with a history of CIN 2, CIN 3, or adenocarcinoma in situ must continue cervical cancer screening for at least 25 years from the initial diagnosis, even if this extends beyond age 65. CDC recommendation. 1

Active Cervical Infection

• Cytology testing should proceed despite active infection; repeat testing after treatment is not routinely required, although a repeat may be considered for specific infections such as chlamydia or gonorrhea. CDC recommendation. 1

Post‑Hysterectomy

• After a total hysterectomy with removal of the cervix, screening is unnecessary unless CIN 2, CIN 3, or adenocarcinoma in situ was diagnosed within the prior 20 years. CDC recommendation. 1
• If a supracervical hysterectomy leaves cervical tissue in place, continue routine Pap testing. CDC recommendation. 1

Common Pitfalls to Avoid

• Do not automatically cancel appointments for menstruating patients who have abnormal bleeding or limited access to care; proceed with screening as scheduled. American Cancer Society guidance. 3
• Do not use Pap smears as screening tools for sexually transmitted infections; they are intended solely for cervical cancer detection. CDC recommendation. 1
• Do not skip Pap testing because of external genital warts; their presence does not alter screening frequency or timing. CDC recommendation. 1

Collection Sequence Considerations

• The order of cytology collection relative to endocervical specimens for STI testing does not affect Pap test results; specimens for STI testing may be collected first, though vaginal samples are generally preferred for chlamydia and gonorrhea screening. CDC recommendation. 1